Form 4 for BIOA BioAge Labs, Inc.
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001210905-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-11 | 2025-12-09 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $12.00 | -18.0K | 0 | -100% | -$216.0K |
| D | 2025-12-11 | 2025-12-09 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $6.57 | +18.0K | 18.0K | New | +$118.3K |
| D | 2025-12-11 | 2025-12-09 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $0.00 | -18.0K | 9,383 | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | S | D | 18,000 | $12.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-09 | M | A | 18,000 | $6.57 | 18,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-12-09 | M | D | 18,000 | $0.00 | 9,383 | D | $6.57 · — to 2032-05-28 | 18,000 Common Stock | (F2) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |